Clinical Trial

Perfusion Imaging Score to Predict Delayed Cerebral Ischemia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Aneurysmal subarachnoid hemorrhage (aSAH) is a significant public health concern, annually affecting over 30,000 Americans and ranking among the leading causes of stroke-related life-years lost in individuals aged 65 and younger. Delayed cerebral ischemia (DCI), occurring in 20% to 40% of aSAH survivors, is a major contributor to brain injury and disability. Timely recognition of DCI is crucial for improving neurological outcomes and preventing irreversible cerebral infarction. However, current methods have substantial limitations, hindering early and reliable detection. This proposal seeks to address these challenges through determining the ability of perfusion imaging to predict DCI and correlate with neurological and neuropsychological outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-12.
Trial Details
NCT Number NCT07030985
Lead Sponsor Stanford University
Conditions Aneurysmal Subarachnoid Hemorrhage, Cerebral Ischemia
Enrollment 55 participants
Start Date 2025-09
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-06-26